NCT00479882
MK-0524B Lipid Study (MK-0524B-063)
See it on ClinicalTrials.gov ↗2,414 people
53.4%
46.6%
1,288 womenmiddle line = equal numbers1,126 men
- Phase
- PHASE3
- Paid for by
- Merck Sharp & Dohme LLC
- Finished
- 2008-06-16
- Health conditions
- Primary Hypercholesterolemia, Mixed Dyslipidemia
- Who could join
- Anyone
- Ages
- 18 Years – 85 Years
- Average age
- Not reported
- Age 65+
- 21%
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- Not reported
Women left out
- No pregnant women
Women who were pregnant could not join.
“is pregnant or breast-feeding, or expecting to conceive during the study including the 14-day post study follow-up”
- No breastfeeding moms
Women who were breastfeeding could not join.
“is pregnant or breast-feeding, or expecting to conceive during the study including the 14-day post study follow-up”
- No kidney or liver problems
Women with kidney or liver problems were turned away.
“…he following conditions: chronic heart failure, uncontrolled/unstable cardiac arrhythmias, unstable hypertension, active or chronic hepatobiliary disorder or hepatic disease, human immunodeficiency virus (HIV) positive, gout (within 1 year)”
- No heart disease
Women with heart disease, heart rhythm problems or a past heart attack were turned away.
“is high risk (coronary heart disease \[CHD\] or CHD risk equivalent) AND is on a statin”
- No diabetes
Women with diabetes were turned away.
“has Type 1 or Type 2 diabetes mellitus and is on statin therapy, is poorly controlled, is newly diagnosed (within 3 months of Visit 1), has recently experienced repeated hypoglycemia or unstable glycemic control or is taking new or recently…”
Study titles and rules are shown in their original English.